ArticleJournal of inflammation research2025
Preliminary Retrospective Analysis of X-Ray, CT, and MRI Imaging Features of Brucellar Spondylodiscitis Diagnosis.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the X-ray, CT, and MRI imaging features of Brucellar spondylodiscitis (BS) across different stages and evaluate their diagnostic value. Methods: Retrospective analysis of imaging features in 137 BS patients (early stage: 40; advanced: 52; recovery: 45) classified by the 2023 Chinese Medical Association Consensus. Diagnostic performances of X-ray, CT, and MRI were compared. Results: Lumbar involvement predominated (98.5%), with 73.7% single-segment cases. X-ray missed 90% of early-stage BS but detected intervertebral stenosis/bone destruction better in advanced/recovery stages (P<0.05). CT excelled in identifying bone destruction (83.9%), sequestration (5.1%), and fractures (6.6%). MRI detected granulomas (85.4%) and abscesses (3.6%) effectively, especially granulomas in advanced-stage (p < 0.05, compared with early stage and recovery stage). CT+MRI synergistically improved staging accuracy for early/advanced BS. Conclusion: CT and MRI are critical for BS staging, with combined use recommended to minimize misdiagnosis and guide treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.